Application of aspirin in the prevention and treatment of liver cancer: Research advances and controversies
10.3969/j.issn.1001-5256.2020.08.037
- VernacularTitle:阿司匹林在肝癌防治中的应用进展与争议
- Author:
Taotao BA
1
;
Peng XIAO
1
;
Mengmeng DING
1
;
Yanhang GAO
1
Author Information
1. Department of Hepatology, The First Hospital of Jilin University, Changchun 130021, China
- Publication Type:Research Article
- Keywords:
liver neoplasms;
aspirin;
therapeutics
- From:
Journal of Clinical Hepatology
2020;36(8):1847-1851
- CountryChina
- Language:Chinese
-
Abstract:
Great achievements have been made in the treatment of liver cancer in recent years. Inflammation plays an important role in the development and progression of liver cancer, while aspirin can exert an anti-inflammatory effect. Basic and clinical studies have found that aspirin can inhibit the development and progression of liver cancer, assist in the comprehensive treatment of liver cancer, and exert an anticancer effect together with other drugs. Aspirin has low costs and is easy to access, and its potential in the adjuvant therapy for liver cancer has attracted great attention; however, there are still many problems and confusions in the application of aspirin in clinical practice. This article summarizes and reviews the recent research advances in aspirin in the prevention and treatment of liver cancer, the problems faced at present, and the future development direction, in order to improve the understanding of this field and lay a foundation for clinical application in the real world in the future.
